Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
Nuclear Medicine Communications|September 29, 2017
Dynamic risk stratification for predicting the recurrence in differentiated thyroid cancerElgin Ozkan, Cigdem Soydal, Demet Nak, et al.
Nuclear Medicine Communications|October 17, 2014
Assessment of recurrence rates in papillary thyroid microcarcinoma patients with and without histopathological risk factors after radioiodine ablation treatmentCigdem Soydal, Mine Araz, Elgin Ozkan, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|May 11, 2018
Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancerCigdem Soydal, Yuksel Urun, Evren Suer, et al.
Clinical Nuclear Medicine|May 11, 2016
Early Response to Everolimus Therapy Detected on 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine TumorElgin Ozkan, Cigdem Soydal, Sibel Ucak Semirgin, et al.
Nuclear Medicine Communications|March 13, 2013
The prognostic value of quantitative parameters of 18F-FDG PET/CT in the evaluation of response to internal radiation therapy with yttrium-90 in patients with liver metastases of colorectal cancerCigdem Soydal, Ozlem N Kucuk, Ethem I Gecim, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|October 12, 2019
Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancerCigdem Soydal, Mine Araz, Yuksel Urun, et al.
Critical Reviews in Oncology/Hematology|December 15, 2025
Sequential use of targeted radioligand therapies in metastatic castration-resistant prostate cancer: A case report and systematic reviewHatice Bölek, Mine Araz, Cigdem Soydal, et al.
Annals of Nuclear Medicine|August 20, 2025
Safety of repeated trans-arterial radioembolization with multi-compartment dosimetryCigdem Soydal, Burak Demir, Mine Araz, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 12, 2025
Integrated Dedicated Liver 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging of Hepatocellular Carcinoma and Correlations of Positron Emission Tomography with Diffusion-Weighted Imaging and Morphological FindingsCigdem Soydal, Burak Demir, Digdem Kuru Oz, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 11, 2016
Prognostic Importance of the Presence of Early Metabolic Response and Absence of Extrahepatic Metastasis After Selective Internal Radiation Therapy in Colorectal Cancer Liver MetastasisCigdem Soydal, Nuriye Ozlem Kucuk, Deniz Balci, et al.
Pageof 7